WO2021062886A1 - Preparation and transformation methods for bacillus subtilis competent cell - Google Patents

Preparation and transformation methods for bacillus subtilis competent cell Download PDF

Info

Publication number
WO2021062886A1
WO2021062886A1 PCT/CN2019/111571 CN2019111571W WO2021062886A1 WO 2021062886 A1 WO2021062886 A1 WO 2021062886A1 CN 2019111571 W CN2019111571 W CN 2019111571W WO 2021062886 A1 WO2021062886 A1 WO 2021062886A1
Authority
WO
WIPO (PCT)
Prior art keywords
bacillus subtilis
electric shock
transformation
competent cells
glycine
Prior art date
Application number
PCT/CN2019/111571
Other languages
French (fr)
Chinese (zh)
Inventor
周辉
Original Assignee
广东普洛宇飞生物科技有限公司
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 广东普洛宇飞生物科技有限公司 filed Critical 广东普洛宇飞生物科技有限公司
Publication of WO2021062886A1 publication Critical patent/WO2021062886A1/en

Links

Images

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20Bacteria; Culture media therefor
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/74Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora
    • C12N15/75Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora for Bacillus

Definitions

  • the present invention belongs to the field of biotechnology, and particularly relates to a method for preparing Bacillus subtilis competence and its transformation.
  • Bacillus subtilis (Bacillus subtilis) is a kind of gram-positive rod-shaped bacteria that is widely distributed in the soil, mesophilic, aerobic and spore-producing. It has strong resistance to stress, and can secrete a large number of enzymes and produce Antibacterial substances, on the one hand, are widely used in the fields of feed, biological control, and environmental protection as live bacteria, and on the other hand, they play an important role in the production of exogenous proteins and metabolites as an expression system.
  • the Gram-positive bacteria expression system possessed by Bacillus subtilis has the ability to express different proteins that many Gram-negative bacteria such as E. coli do not possess. Compared with our commonly used E.
  • the Bacillus subtilis expression system has The following advantages: 1) It has a strong secretion and expression ability, and can directly secrete the expressed foreign protein outside the cell to avoid the aggregation of the protein in the cell. The recovery of the purified protein is relatively simple, which is conducive to downstream operations; 2) Belongs The GRAS strain can be safely used for the production of food and pharmaceutical proteins; 3) There is no obvious codon preference, which avoids codon optimization.
  • Bacillus subtilis The introduction of foreign genes is an important step in the application of Bacillus subtilis as an expression system.
  • the transformation efficiency of Bacillus subtilis is far lower than that of Escherichia coli, which limits its use in protein engineering (such as directed evolution, protein mutant library, etc.) and Application of metabolic transformation.
  • proteins engineering such as directed evolution, protein mutant library, etc.
  • Genetic transformation As early as 1958, studies have found that Bacillus subtilis strains have the ability to form natural competence, and the formation of competence is the result of highly ordered genetic regulation in the later stage of growth, but the proportion of Bacillus subtilis that naturally form competent cells Smaller, and the duration is shorter.
  • the currently reported methods to improve the transformation efficiency of Bacillus subtilis mainly include polymer method, electroporation method and protoplasm method. However, the polymer method requires the construction of polymer plasmids.
  • the protoplast method is fragile, which makes the preparation of Bacillus subtilis protoplasts.
  • the body is difficult and very cumbersome.
  • the electroporation transformation method is a commonly used method for Bacillus subtilis. Its operation is simple, the experiment is easy to control, and the reproducibility is good. However, the electrotransformation conditions have a great impact on the transformation of competent cells.
  • the current electroporation transformation efficiency is generally not high. Can not meet the needs of the experiment, so it is necessary to establish a method for efficient transformation of Bacillus subtilis.
  • the first object of the present invention is to provide a cell wall weakening agent for preparing Bacillus subtilis competent cells, the cell wall weakening agent comprising the following components: glycine, serine and dithiothreitol (DTT).
  • DTT dithiothreitol
  • the concentration of the glycine, serine and dithiothreitol in the cell wall weakening agent is 0.5-1% (W/V) for glycine and 0.5-1% (W/V) for serine , Dithiothreitol is 1-10mM.
  • the concentration of the glycine, serine and dithiothreitol in the cell wall weakening agent is: glycine is 0.6-0.8% (W/V), serine is 0.7-0.9% (W/V) , Dithiothreitol is 5-7mM.
  • the concentration of the glycine, serine and dithiothreitol in the cell wall weakening agent is: glycine is 0.6% (W/V), serine is 0.9% (W/V), dithiothreon Sugar alcohol is 6mM.
  • the conversion rate of Bacillus subtilis competent cells is higher when the concentration of dithiothreitol is in the range of 5-7 mM; the conversion efficiency is highest when glycine is 0.6%, serine is 0.9%, and dithiothreitol is 6 mM.
  • the second object of the present invention is to provide a method for electric shock transformation of Bacillus subtilis competent cells, which includes two steps of preparing competent cells and electric shock transformation, wherein the preparing competent cells sequentially includes the following steps:
  • step (2) Add the cell wall weakening agent of the present invention to the culture in step (1) and continue to culture until the OD600 value reaches 0.9;
  • step (3) Centrifuge the culture obtained in step (2) in an ice bath to collect Bacillus subtilis cells;
  • GM growth medium tryptone 1% (W/V), yeast extract 0.5% (W/V), NaCl 0.5% (W/V), hydrolyzed casein 0.2% (W/V), 500 mM sorbitol, 500 mM glucose, 50 mM K 2 HPO 4 , 50 mM KH 2 PO 4 .
  • the components of the WB shock buffer are: 500 mM trehalose, 500 mM sorbitol, 500 mM mannitol, 0.5 mM K 2 HPO 4 , 0.5 mM KH 2 PO 4 , 15 mM MgCl 2 , 85 mM CaCl 2 , pH 7.2.
  • the electric shock conversion includes the following steps:
  • the plasmid to be transformed and the competent cell are mixed and bathed in ice, and subjected to electric shock. After electric shock transformation, heat shock at 30° C. for 5 min; to obtain the recombinant Bacillus subtilis which is introduced into the transformation treatment.
  • the electric shock parameters are: voltage 20kv/cm, capacitance 25 ⁇ F, resistance 200 ⁇ , electric shock 1 time, duration 5ms.
  • the step of electroporation transformation further includes adding the recombinant Bacillus subtilis transformed by electroporation to RM resuscitation medium, culturing at 37°C for 3-6 hours, and then coating the LB plate;
  • the components of the RM recovery medium are tryptone 1% (W/V), yeast extract 0.5% (W/V), NaCl 0.5% (W/V), sorbitol 500 mM, 350 mM mannitol.
  • Bacillus subtilis is one of Bacillus subtilis ZK, Bacillus subtilis DB104 or Bacillus subtilis WB600.
  • the plasmid is a shuttle plasmid PHT01 or PHT304.
  • the present invention improves the preparation and transformation method of Bacillus subtilis electro-transformed competent cells.
  • the growth medium GM is used for cultivation, and
  • the cell wall weakening agent with optimized concentration was added during the preparation process, and the resuscitation medium RM was used for resuscitation culture after electric shock transformation.
  • the prepared competent cells of Bacillus subtilis had a great transformation efficiency compared with the traditional method of preparing competent cells.
  • the improvement of the preparation process is simple, the experiment is easy to control, and the repeatability is good.
  • Figure 1 shows the electrophoresis diagram of PHT01 plasmid transformation.
  • Figure 2 is the electrophoresis diagram of PHT304 plasmid transformation.
  • Figure 3 is a schematic diagram of the effect of adding different concentrations of glycine, threonine, and DTT on the transformation efficiency of Bacillus subtilis.
  • Figure 4 is a schematic diagram showing the effect of different ratios of glycine, threonine, and DDT combination on the transformation efficiency of Bacillus subtilis.
  • primers were designed to amplify the Bacillus subtilis strain as a template.
  • the primer sequences were P1: CGGGATCCACATTGAAAGGGGAGGAGAAT, P2: GCTCTAGACGTCCTCTCTGCTCTTCTATC, The 5 ends were introduced with BamHI and XbaI restriction sites, and the gel was recovered for use after amplification.
  • the PHT01 plasmid was double digested with BamHI and XbaI endonuclease and recovered after digestion.
  • the Bacillus subtilis selected in this embodiment is Bacillus subtilis ZK.
  • the restriction conditions are as follows:
  • connection conditions are as follows:
  • connection system in a 16°C water bath and connect overnight.
  • the ligated product was transformed into Escherichia coli DH-5a, and the amp-resistant LB plate was used for screening, a single clone was picked and sequenced to confirm the successful construction of the vector.
  • LB medium preparation 1% (W/V) tryptone, 0.5% (W/V) yeast extract, 1% (W/V) sodium chloride, sterilized at 121°C for 15 min.
  • GM medium (growth medium) preparation tryptone 1% (W/V), yeast extract 0.5% (W/V), NaCl 0.5% (W/V), hydrolyzed casein 0.2% (W/V) ), 500mM sorbitol, 500mM glucose, 50mM K 2 HPO 4 , 50 mM KH 2 PO 4 , sterilized at 115°C for 15 min.
  • Cell wall weakening agent (WA solution preparation 10 ⁇ ): 5% (W/V) glycine, 10% (W/V) serine, 5 mmol DTT. Glycine and serine are sterilized by filtration with a 0.22um filter membrane and sterilized by DTT at 121°C for 15 minutes.
  • WB buffer shock buffer
  • 500mM trehalose 500mM sorbitol
  • 500mM mannitol 15mM MgCl 2
  • 0.5mM K 2 HPO 4 0.5mM KH 2 PO 4
  • 10% glycerol adjust pH Sterilize at 121°C for 15 minutes to 7.2.
  • RM medium resuscitation medium: tryptone 1% (W/V), yeast extract 0.5% (W/V), NaCl 0.5% (W/V), sorbitol 500 mM, 350 mM mannitol , Sterilize at 121°C for 15min.
  • step (1) Transfer the system of step (1) to an electric shock cup (1mm) pre-cooled at 0°C, and perform an electric shock with an electric transfer instrument (voltage 20kv/cm, capacitance 25 ⁇ F, resistance 200 ⁇ , electric shock 1 time, duration 5ms) ;
  • the transformation rate is the number of transformants produced per ⁇ g of plasmid DNA.
  • Transformation efficiency total number of transformants/addition of plasmid DNA
  • Total number of transformants number of colonies ⁇ dilution times ⁇ total volume of transformation reaction stock solution/volume of plate-coated bacteria solution.
  • the conversion rate calculated according to the above formula is 7.8 ⁇ 10 7 cfu/ ⁇ g. According to the results of agarose gel electrophoresis, the DNA bands are clear as shown in lanes 1, 2 and 3 in Figure 1.
  • the conversion rate calculated according to the above formula is 5.9 ⁇ 10 7 cfu/ ⁇ g. According to the results of agarose gel electrophoresis, the DNA bands are clear as shown in lanes 1, 2, and 3 in Figure 2.
  • the LB medium, GM medium, WB buffer, and RM medium of this example are the same as those in Example 1.
  • step (1) Transfer the system of step (1) to an electric shock cup (1mm) pre-cooled at 0°C, and perform an electric shock with an electric transfer instrument (voltage 20kv/cm, capacitance 25 ⁇ F, resistance 200 ⁇ , electric shock 1 time, duration 5ms) ;
  • the transformation rate is the number of transformants produced per ⁇ g of plasmid DNA.

Landscapes

  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Plant Pathology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Medicinal Chemistry (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

A cell wall weakening agent for preparing a bacillus subtilis competent cell, comprising the following components: glycine, serine, and dithiothreitol. The provided cell wall weakening agent can improve the transformation efficiency of bacillus subtilis. Also provided is a transformation method for a bacillus subtilis competent cell by electroporation.

Description

一种枯草芽孢杆菌感受态细胞的制备及转化方法Preparation and transformation method of Bacillus subtilis competent cell 技术领域Technical field
本发明为生物技术领域,尤其涉及一种枯草芽孢杆菌感受态的制备及其转化方法。The present invention belongs to the field of biotechnology, and particularly relates to a method for preparing Bacillus subtilis competence and its transformation.
背景技术Background technique
枯草芽孢杆菌(Bacillus subtilis)是一种广泛分布在土壤中,嗜温、好氧并产芽孢的革兰氏阳性杆状细菌,其具有很强的抗逆性,并能分泌大量酶类和产生抗菌物质,因此,一方面作为活菌剂被广泛应用在饲料、生防、环保等领域,另一方面作为表达系统在外源蛋白和代谢产物的生产中发挥重要作用。枯草芽孢杆菌所拥有的革兰氏阳性菌表达系统,具有许多革兰氏阴性菌如大肠杆菌不具备的不同蛋白的表达能力,与我们常用的大肠杆菌表达系统相比,枯草芽孢杆菌表达系统具有以下的优势:1)具有很强的分泌表达能力,能将表达的外源蛋白直接分泌到细胞外从而避免了蛋白在细胞内的聚集,回收纯化蛋白比较简单,有利于下游操作;2)属于GRAS菌株,可安全用于生产食品、医药蛋白;3)没有明显的密码子偏爱性,避免了密码子优化。Bacillus subtilis (Bacillus subtilis) is a kind of gram-positive rod-shaped bacteria that is widely distributed in the soil, mesophilic, aerobic and spore-producing. It has strong resistance to stress, and can secrete a large number of enzymes and produce Antibacterial substances, on the one hand, are widely used in the fields of feed, biological control, and environmental protection as live bacteria, and on the other hand, they play an important role in the production of exogenous proteins and metabolites as an expression system. The Gram-positive bacteria expression system possessed by Bacillus subtilis has the ability to express different proteins that many Gram-negative bacteria such as E. coli do not possess. Compared with our commonly used E. coli expression system, the Bacillus subtilis expression system has The following advantages: 1) It has a strong secretion and expression ability, and can directly secrete the expressed foreign protein outside the cell to avoid the aggregation of the protein in the cell. The recovery of the purified protein is relatively simple, which is conducive to downstream operations; 2) Belongs The GRAS strain can be safely used for the production of food and pharmaceutical proteins; 3) There is no obvious codon preference, which avoids codon optimization.
外源基因的导入是枯草芽孢杆菌作为表达系统应用的重要一步,然而枯草芽孢杆菌的转化效率远远低于大肠杆菌,这限制了其在蛋白质工程(如定向进化、蛋白质突变体库等)以及代谢改造的应用。早在1958年,研究就发现枯草芽孢杆菌菌株具有形成自然感受态的能力,且感受态的形成是生长后期高度有序的遗传调控的结果,但是自然形成感受态细胞的枯草芽孢杆菌所占比例较小,且持续的时间较短。目前报道的提高枯草芽孢杆菌转化效率的方法主要有多聚体法、电穿孔法以及原生质法,但是多聚体法需要构建多聚体的质粒,原生质法原生质体脆弱,使得制备枯草芽孢杆菌原生质体困难且十分繁琐。电击转化方法是枯草芽孢杆菌比较常用的转化方法,其操作简单,实验容易控制,重复性较好,但是电转化的条件对感受态细胞的转化影响很大,目前电击转化的效率普遍不高,不能满足实验的需求,因此有必要建立一种枯草芽孢杆菌高效转 化的方法。The introduction of foreign genes is an important step in the application of Bacillus subtilis as an expression system. However, the transformation efficiency of Bacillus subtilis is far lower than that of Escherichia coli, which limits its use in protein engineering (such as directed evolution, protein mutant library, etc.) and Application of metabolic transformation. As early as 1958, studies have found that Bacillus subtilis strains have the ability to form natural competence, and the formation of competence is the result of highly ordered genetic regulation in the later stage of growth, but the proportion of Bacillus subtilis that naturally form competent cells Smaller, and the duration is shorter. The currently reported methods to improve the transformation efficiency of Bacillus subtilis mainly include polymer method, electroporation method and protoplasm method. However, the polymer method requires the construction of polymer plasmids. The protoplast method is fragile, which makes the preparation of Bacillus subtilis protoplasts. The body is difficult and very cumbersome. The electroporation transformation method is a commonly used method for Bacillus subtilis. Its operation is simple, the experiment is easy to control, and the reproducibility is good. However, the electrotransformation conditions have a great impact on the transformation of competent cells. The current electroporation transformation efficiency is generally not high. Can not meet the needs of the experiment, so it is necessary to establish a method for efficient transformation of Bacillus subtilis.
发明内容Summary of the invention
本发明的第一个目的在于提供一种用于制备枯草芽孢杆菌感受态细胞的细胞壁弱化剂,所述细胞壁弱化剂包括以下组分:甘氨酸、丝氨酸和二硫苏糖醇(DTT)。经本发明人研究显示,在枯草芽孢杆菌培养物中加入本发明所述的细胞壁弱化剂再培养一段时间后,所获得的枯草芽孢杆菌感受态细胞能提高转化效率。The first object of the present invention is to provide a cell wall weakening agent for preparing Bacillus subtilis competent cells, the cell wall weakening agent comprising the following components: glycine, serine and dithiothreitol (DTT). The inventor's research shows that after adding the cell wall weakening agent of the present invention to the Bacillus subtilis culture and culturing for a period of time, the obtained Bacillus subtilis competent cells can improve the transformation efficiency.
优选地,所述甘氨酸、丝氨酸和二硫苏糖醇的浓度在所述细胞壁弱化剂中的浓度为:甘氨酸为0.5~1%(W/V),丝氨酸为0.5~1%(W/V),二硫苏糖醇为1~10mM。Preferably, the concentration of the glycine, serine and dithiothreitol in the cell wall weakening agent is 0.5-1% (W/V) for glycine and 0.5-1% (W/V) for serine , Dithiothreitol is 1-10mM.
优选地,所述甘氨酸、丝氨酸和二硫苏糖醇的浓度在所述细胞壁弱化剂中的浓度为:甘氨酸为0.6~0.8%(W/V),丝氨酸为0.7~0.9%(W/V),二硫苏糖醇为5~7mM。Preferably, the concentration of the glycine, serine and dithiothreitol in the cell wall weakening agent is: glycine is 0.6-0.8% (W/V), serine is 0.7-0.9% (W/V) , Dithiothreitol is 5-7mM.
优选地,所述甘氨酸、丝氨酸和二硫苏糖醇的浓度在所述细胞壁弱化剂中的浓度为:甘氨酸为0.6%(W/V),丝氨酸为0.9%(W/V),二硫苏糖醇为6mM。Preferably, the concentration of the glycine, serine and dithiothreitol in the cell wall weakening agent is: glycine is 0.6% (W/V), serine is 0.9% (W/V), dithiothreon Sugar alcohol is 6mM.
本发明人通过对单独加入不同浓度的甘氨酸,苏氨酸,DTT对枯草芽孢杆菌感受态细胞转化率的影响研究结果表明,当甘氨酸的浓度为0.6~0.8%,丝氨酸的浓度为0.7~0.9%,二硫苏糖醇的浓度为5~7mM范围内枯草芽孢杆菌感受态细胞转化率较高;其中又以甘氨酸为0.6%,丝氨酸为0.9%,二硫苏糖醇为6mM时转化效率最高。The inventors studied the effects of different concentrations of glycine, threonine, and DTT on the transformation rate of Bacillus subtilis competent cells. The results show that when the concentration of glycine is 0.6-0.8%, the concentration of serine is 0.7-0.9%. The conversion rate of Bacillus subtilis competent cells is higher when the concentration of dithiothreitol is in the range of 5-7 mM; the conversion efficiency is highest when glycine is 0.6%, serine is 0.9%, and dithiothreitol is 6 mM.
本发明的第二个目的在于提供一种枯草芽孢杆菌感受态细胞的电击转化方法,包括制备感受态细胞和电击转化两个步骤,其中,所述制备感受态细胞依次包括以下步骤:The second object of the present invention is to provide a method for electric shock transformation of Bacillus subtilis competent cells, which includes two steps of preparing competent cells and electric shock transformation, wherein the preparing competent cells sequentially includes the following steps:
(1)将枯草芽孢杆菌接种至LB基本培养基中过夜培养,再将其接种于GM生长培养基中培养;(1) Inoculate Bacillus subtilis into LB basic medium for overnight cultivation, and then inoculate it into GM growth medium for cultivation;
(2)在步骤(1)中培养物中加入本发明的细胞壁弱化剂继续培养至OD600的值达到0.9;(2) Add the cell wall weakening agent of the present invention to the culture in step (1) and continue to culture until the OD600 value reaches 0.9;
(3)将步骤(2)获得的培养物冰浴,离心收集枯草芽孢杆菌细胞;(3) Centrifuge the culture obtained in step (2) in an ice bath to collect Bacillus subtilis cells;
(4)使用预冷的WB电击缓冲液清洗细胞,再将获得的细胞用WB电击缓冲液重悬,放入液氮中速冻,-80℃保存;(4) Wash the cells with pre-cooled WB shock buffer, then resuspend the obtained cells in WB shock buffer, quickly freeze in liquid nitrogen, and store at -80°C;
GM生长培养基的组分为:胰蛋白胨1%(W/V),酵母提取物0.5%(W/V),NaCl 0.5%(W/V),水解酪蛋白0.2%(W/V),500mM的山梨醇,500mM的葡糖糖,50mM K 2HPO 4,50mM KH 2PO 4The components of GM growth medium are: tryptone 1% (W/V), yeast extract 0.5% (W/V), NaCl 0.5% (W/V), hydrolyzed casein 0.2% (W/V), 500 mM sorbitol, 500 mM glucose, 50 mM K 2 HPO 4 , 50 mM KH 2 PO 4 .
WB电击缓冲液的组分为:500mM的海藻糖,500mM的山梨醇,500mM的甘露醇,0.5mM K 2HPO 4,0.5mM KH 2PO 4,15mM MgCl 2,85mM CaCl 2,pH值7.2。 The components of the WB shock buffer are: 500 mM trehalose, 500 mM sorbitol, 500 mM mannitol, 0.5 mM K 2 HPO 4 , 0.5 mM KH 2 PO 4 , 15 mM MgCl 2 , 85 mM CaCl 2 , pH 7.2.
所述电击转化包括如下步骤:The electric shock conversion includes the following steps:
将待转化的质粒与所述感受态细胞混匀并冰浴,并进行电击,电击转化后于30℃热激5min;得到导入所述待转化治疗的重组枯草芽孢杆菌。The plasmid to be transformed and the competent cell are mixed and bathed in ice, and subjected to electric shock. After electric shock transformation, heat shock at 30° C. for 5 min; to obtain the recombinant Bacillus subtilis which is introduced into the transformation treatment.
优选地,所述步骤(1)中接种于GM培养基的接种量为1:100,在GM培养基培养至OD600=0.6。Preferably, the amount of inoculation in the GM medium in the step (1) is 1:100, and the inoculum is cultivated in the GM medium to OD600=0.6.
所述电击参数为:电压20kv/cm,电容25μF,电阻200Ω,电击1次,持续时间5ms。The electric shock parameters are: voltage 20kv/cm, capacitance 25μF, resistance 200Ω, electric shock 1 time, duration 5ms.
优选地,所述步骤电击转化还包括将电击转化后的重组枯草芽孢杆菌加入RM复苏培养基于37℃培养3-6小时后涂LB平板;Preferably, the step of electroporation transformation further includes adding the recombinant Bacillus subtilis transformed by electroporation to RM resuscitation medium, culturing at 37°C for 3-6 hours, and then coating the LB plate;
所述RM复苏培养基的组分为胰蛋白胨1%(W/V),酵母提取物0.5%(W/V),NaCl 0.5%(W/V),山梨糖醇500mM,350mM的甘露醇。The components of the RM recovery medium are tryptone 1% (W/V), yeast extract 0.5% (W/V), NaCl 0.5% (W/V), sorbitol 500 mM, 350 mM mannitol.
优选地,所述枯草芽孢杆菌为枯草芽孢杆菌ZK、枯草芽孢杆菌DB104或枯草芽孢杆菌WB600的其中一种。Preferably, the Bacillus subtilis is one of Bacillus subtilis ZK, Bacillus subtilis DB104 or Bacillus subtilis WB600.
优选地,所述质粒为穿梭质粒PHT01或PHT304。Preferably, the plasmid is a shuttle plasmid PHT01 or PHT304.
本发明的有益效果:本发明在现有技术的基础上,改进了枯草芽孢杆菌电转化感受态细胞的制备与转化方法,在常规LB基本培养基培养后使用生长培养基GM进行培养,并在制备的过程中添加经浓度优化的细胞壁弱化剂,电击转化后使用复苏培养基RM进行复苏培养,制备出的枯草芽孢杆菌的感受态细胞对比传统感受态细胞的制备方法转化效率上有了很大的提高,且制备过程操作简单,实验容易控制,重复性较好。The beneficial effects of the present invention: on the basis of the prior art, the present invention improves the preparation and transformation method of Bacillus subtilis electro-transformed competent cells. After the conventional LB basic medium is cultivated, the growth medium GM is used for cultivation, and The cell wall weakening agent with optimized concentration was added during the preparation process, and the resuscitation medium RM was used for resuscitation culture after electric shock transformation. The prepared competent cells of Bacillus subtilis had a great transformation efficiency compared with the traditional method of preparing competent cells. The improvement of the preparation process is simple, the experiment is easy to control, and the repeatability is good.
附图说明Description of the drawings
图1为PHT01质粒转化电泳图。Figure 1 shows the electrophoresis diagram of PHT01 plasmid transformation.
图2为PHT304质粒转化电泳图。Figure 2 is the electrophoresis diagram of PHT304 plasmid transformation.
图3为单独加入不同浓度的甘氨酸、苏氨酸、DTT对枯草芽孢杆菌转化效率的影响示意图。Figure 3 is a schematic diagram of the effect of adding different concentrations of glycine, threonine, and DTT on the transformation efficiency of Bacillus subtilis.
图4为不同比例甘氨酸,苏氨酸,DDT组合对枯草芽孢杆菌转化效率的影响示意图。Figure 4 is a schematic diagram showing the effect of different ratios of glycine, threonine, and DDT combination on the transformation efficiency of Bacillus subtilis.
具体实施方式Detailed ways
为了更加简洁明了的展示本发明的技术方案、目的和优点,下面结合具体实施例及其附图对本发明做进一步的详细描述。In order to show the technical solutions, objectives and advantages of the present invention more concisely and clearly, the present invention will be further described in detail below in conjunction with specific embodiments and the accompanying drawings.
实施例1枯草芽孢杆菌耐高温α-淀粉酶的转化Example 1 Transformation of Bacillus subtilis high-temperature-resistant α-amylase
1、载体的构建1. Construction of the vector
根据NCBI已公布的枯草芽孢杆菌耐高温α-淀粉酶基因序列,设计引物以枯草芽孢杆菌菌种为模板对其进行扩增,所述引物序列为P1:CGGGATCCACATTGAAAGGGGAGGAGAAT,P2:GCTCTAGACGTCCTCTCTGCTCTTCTATC,所述引物的5端分别引入BamHI与XbaI酶切位点,扩增后凝胶回收备用。使用BamHI与XbaI内切酶对PHT01 质粒进行双酶切,酶切后回收。本实施例选用的枯草芽孢杆菌为枯草芽孢杆菌ZK。According to the Bacillus subtilis thermostable alpha-amylase gene sequence published by NCBI, primers were designed to amplify the Bacillus subtilis strain as a template. The primer sequences were P1: CGGGATCCACATTGAAAGGGGAGGAGAAT, P2: GCTCTAGACGTCCTCTCTGCTCTTCTATC, The 5 ends were introduced with BamHI and XbaI restriction sites, and the gel was recovered for use after amplification. The PHT01 plasmid was double digested with BamHI and XbaI endonuclease and recovered after digestion. The Bacillus subtilis selected in this embodiment is Bacillus subtilis ZK.
酶切条件如下:The restriction conditions are as follows:
Figure PCTCN2019111571-appb-000001
Figure PCTCN2019111571-appb-000001
将酶切体系放入37℃槽中,水浴3hPut the digestion system into a 37°C tank, and water bath for 3h
连接条件如下:The connection conditions are as follows:
Figure PCTCN2019111571-appb-000002
Figure PCTCN2019111571-appb-000002
将连接体系放入16℃的水浴槽中,过夜连接。将连接的产物转化至大肠杆菌DH-5a,使用amp抗性的LB平板进行筛选,挑取单克隆并测序确认构建成功的载体。Put the connection system in a 16°C water bath and connect overnight. The ligated product was transformed into Escherichia coli DH-5a, and the amp-resistant LB plate was used for screening, a single clone was picked and sequenced to confirm the successful construction of the vector.
2、试剂的配制2. Preparation of reagents
LB培养基的配制:1%(W/V)胰蛋白胨,0.5%(W/V)酵母提取物,1%(W/V)氯化钠,121℃灭菌15min。LB medium preparation: 1% (W/V) tryptone, 0.5% (W/V) yeast extract, 1% (W/V) sodium chloride, sterilized at 121°C for 15 min.
GM培养基(生长培养基)的配制:胰蛋白胨1%(W/V),酵母提取物0.5%(W/V),NaCl 0.5%(W/V),水解酪蛋白0.2%(W/V),500mM的山梨醇,500mM的葡糖,50mM K 2HPO 4,50mM KH 2PO 4,115℃灭菌15min。 GM medium (growth medium) preparation: tryptone 1% (W/V), yeast extract 0.5% (W/V), NaCl 0.5% (W/V), hydrolyzed casein 0.2% (W/V) ), 500mM sorbitol, 500mM glucose, 50mM K 2 HPO 4 , 50 mM KH 2 PO 4 , sterilized at 115°C for 15 min.
细胞壁弱化剂(WA溶液配制10×):5%(W/V)甘氨酸,10%(W/V)丝氨酸,5mmol DTT。甘氨酸,丝氨酸使用0.22um滤膜过滤除菌,DTT 121℃灭菌15分钟。Cell wall weakening agent (WA solution preparation 10×): 5% (W/V) glycine, 10% (W/V) serine, 5 mmol DTT. Glycine and serine are sterilized by filtration with a 0.22um filter membrane and sterilized by DTT at 121°C for 15 minutes.
WB缓冲液(电击缓冲液)的配制:500mM的海藻糖,500mM的山梨醇,500mM的甘露醇,15mM MgCl 2,0.5mM K 2HPO 4,0.5mM KH 2PO 4,10%甘油,调节PH至7.2,121℃灭菌15min。 Preparation of WB buffer (shock buffer): 500mM trehalose, 500mM sorbitol, 500mM mannitol, 15mM MgCl 2 , 0.5mM K 2 HPO 4 , 0.5mM KH 2 PO 4 , 10% glycerol, adjust pH Sterilize at 121°C for 15 minutes to 7.2.
RM培养基(复苏培养基)的配制:胰蛋白胨1%(W/V),酵母提取物0.5%(W/V),NaCl 0.5%(W/V),山梨糖醇500mM,350mM的甘露醇,121℃灭菌15min。Preparation of RM medium (resuscitation medium): tryptone 1% (W/V), yeast extract 0.5% (W/V), NaCl 0.5% (W/V), sorbitol 500 mM, 350 mM mannitol , Sterilize at 121℃ for 15min.
3、枯草芽孢杆菌感受态细胞的制备3. Preparation of Bacillus subtilis competent cells
(1)挑取枯草芽孢杆菌单克隆于2ml LB培养基中过夜培养12-14小时,培养温度为32℃,转速200rpm;(1) Pick out a single clone of Bacillus subtilis and culture it overnight in 2ml LB medium for 12-14 hours at a temperature of 32°C and a rotation speed of 200rpm;
(2)取400ul的上述步骤(1)的培养物接种于40ml GM培养基中,32℃,200rpm培养至OD600=0.6;(2) Take 400ul of the culture of the above step (1) and inoculate it in 40ml GM medium, cultivate at 32°C and 200rpm to OD600=0.6;
(3)加入细胞壁弱化剂,其中甘氨酸、丝氨酸、DTT的终浓度分别为0.5%(W/V)、1%(W/V)、0.5mmol,37℃,200rpm继续培养至OD600的值达到0.9;(3) Add a cell wall weakening agent, where the final concentrations of glycine, serine, and DTT are 0.5% (W/V), 1% (W/V), 0.5 mmol, 37°C, 200 rpm, and continue to culture until the OD600 value reaches 0.9 ;
(4)冰浴10min,离心收集枯草芽孢杆菌细胞(10000g,4℃),使用预冷的WB缓冲液清洗3次,最后使用100ul的WB缓冲液重悬,放入液氮中速冻,-80℃保存;(4) Ice bath for 10 minutes, collect Bacillus subtilis cells by centrifugation (10000g, 4℃), wash 3 times with pre-cooled WB buffer, and finally resuspend in 100ul of WB buffer, and put it in liquid nitrogen for quick freezing, -80 Store at ℃;
4、电击转化4. Electric shock conversion
(1)取-80℃保存的枯草芽孢杆菌菌种于冰上自然融化,融化后加入100ng 待转化的质粒,冰浴5分钟后进行电击;(1) Take the Bacillus subtilis strain stored at -80°C and melt it naturally on ice, add 100ng of the plasmid to be transformed after melting, and perform electric shock after ice bath for 5 minutes;
(2)将步骤(1)的体系转移至0℃预冷的电击杯(1mm)中,用电转仪进行电击(电压20kv/cm,电容25μF,电阻200Ω,电击1次,持续时间5ms);(2) Transfer the system of step (1) to an electric shock cup (1mm) pre-cooled at 0℃, and perform an electric shock with an electric transfer instrument (voltage 20kv/cm, capacitance 25μF, resistance 200Ω, electric shock 1 time, duration 5ms) ;
(3)电击转化后于30℃热激5min;(3) Heat shock at 30℃ for 5min after electric shock conversion;
(4)加入1ml的RM培养基于37℃培养3-6小时后涂在含有相应抗生素的LB平板。(4) Add 1ml of RM medium and incubate at 37°C for 3-6 hours, then spread it on an LB plate containing corresponding antibiotics.
(5)计数菌落,计算转化率,转化率为每μg质粒DNA产生的转化子数。(5) Count the colonies and calculate the transformation rate. The transformation rate is the number of transformants produced per μg of plasmid DNA.
转化效率的计算公式为:The calculation formula of conversion efficiency is:
转化效率=转化子总数/质粒DNA加入量Transformation efficiency = total number of transformants/addition of plasmid DNA
转化子总数=菌落数×稀释倍数×转化反应原液总体积/涂板菌液体积。Total number of transformants=number of colonies×dilution times×total volume of transformation reaction stock solution/volume of plate-coated bacteria solution.
按照上述公式计算得到的转化率为7.8×10 7cfu/μg,根据琼脂糖凝胶电泳结果显示如图1中泳道1,2,3所示,DNA条带清晰。 The conversion rate calculated according to the above formula is 7.8×10 7 cfu/μg. According to the results of agarose gel electrophoresis, the DNA bands are clear as shown in lanes 1, 2 and 3 in Figure 1.
实施例2Example 2
本实施例与实施例1的唯一区别在于:本实施例选用的穿梭质粒为PHT304,选用的枯草芽孢杆菌为枯草芽孢杆菌DB104。The only difference between this embodiment and embodiment 1 is that the shuttle plasmid used in this embodiment is PHT304, and the selected Bacillus subtilis is Bacillus subtilis DB104.
按照上述公式计算得到的转化率为5.9×10 7cfu/μg,根据琼脂糖凝胶电泳结果显示如图2中泳道1,2,3所示,DNA条带清晰。 The conversion rate calculated according to the above formula is 5.9×10 7 cfu/μg. According to the results of agarose gel electrophoresis, the DNA bands are clear as shown in lanes 1, 2, and 3 in Figure 2.
实施例3Example 3
本实施例通过单独加入不同终浓度的甘氨酸,苏氨酸和DTT研究WA溶液中3种组分对枯草芽孢杆菌转化率影响,本实施例选用的穿梭质粒为PHT01,选用的枯草芽孢杆菌为枯草芽孢杆菌WB600。具体如下:In this example, the influence of the three components in the WA solution on the transformation rate of Bacillus subtilis was studied by separately adding glycine, threonine and DTT at different final concentrations. The shuttle plasmid selected in this example was PHT01, and the selected Bacillus subtilis was subtilis. Bacillus WB600. details as follows:
1、枯草芽孢杆菌感受态细胞的制备:1. Preparation of Bacillus subtilis competent cells:
(1)挑取枯草芽孢杆菌单克隆于2ml LB培养基中过夜培养12-14小时,培养温度为32℃,转速200rpm;(1) Pick out a single clone of Bacillus subtilis and culture it overnight in 2ml LB medium for 12-14 hours at a temperature of 32°C and a rotation speed of 200rpm;
(2)取400ul的上述培养物接种于40ml GM培养基中,32℃,200rpm培养至OD600=0.6;(2) Inoculate 400ul of the above-mentioned culture in 40ml GM medium, cultivate at 32°C and 200rpm to OD600=0.6;
(3)单独加入不同浓度的甘氨酸,苏氨酸,DTT(二硫苏糖醇),使其终浓度分别为:甘氨酸(0.5%,0.6%,0.7%,0.8%,0.9%,1%),丝氨酸(0.5%,0.6%,0.7%,0.8%,0.9%,1%),DTT(1mM,2mM,3mM,4mM,5mM,6mM,7mM,8mM,9mM,10mM)溶液,37℃,200rpm继续培养至OD600的值达到0.9;(3) Separately add different concentrations of glycine, threonine, and DTT (dithiothreitol) to make the final concentrations: glycine (0.5%, 0.6%, 0.7%, 0.8%, 0.9%, 1%) , Serine (0.5%, 0.6%, 0.7%, 0.8%, 0.9%, 1%), DTT (1mM, 2mM, 3mM, 4mM, 5mM, 6mM, 7mM, 8mM, 9mM, 10mM) solution, 37℃, 200rpm Continue to cultivate until the value of OD600 reaches 0.9;
(4)冰浴10min,离心收集枯草芽孢杆菌细胞(10000g,4℃),使用预冷的WB缓冲液清洗3次,最后使用100ul的WB缓冲液重悬,放入液氮中速冻,-80℃保存;(4) Ice bath for 10 minutes, collect Bacillus subtilis cells by centrifugation (10000g, 4℃), wash 3 times with pre-cooled WB buffer, and finally resuspend in 100ul of WB buffer, and put it in liquid nitrogen for quick freezing, -80 Store at ℃;
本实施例的LB培养基、GM培养基、WB缓冲液、RM培养基均与实施例1相同。The LB medium, GM medium, WB buffer, and RM medium of this example are the same as those in Example 1.
2、电击转化2. Electric shock conversion
(1)取-80℃保存的枯草芽孢杆菌菌种于冰上自然融化,融化后加入100ng待转化的质粒,冰浴5分钟后进行电击;(1) Take the Bacillus subtilis strain stored at -80°C and melt it naturally on ice, add 100ng of the plasmid to be transformed after melting, and perform electric shock after ice bath for 5 minutes;
(2)将步骤(1)的体系转移至0℃预冷的电击杯(1mm)中,用电转仪进行电击(电压20kv/cm,电容25μF,电阻200Ω,电击1次,持续时间5ms);(2) Transfer the system of step (1) to an electric shock cup (1mm) pre-cooled at 0℃, and perform an electric shock with an electric transfer instrument (voltage 20kv/cm, capacitance 25μF, resistance 200Ω, electric shock 1 time, duration 5ms) ;
(3)电击转化后于30℃热激5min;(3) Heat shock at 30℃ for 5min after electric shock conversion;
(4)加入1ml的RM培养基于37℃培养3-6小时后涂在含有相应抗生素的LB平板。(4) Add 1ml of RM medium and incubate at 37°C for 3-6 hours, then spread it on an LB plate containing corresponding antibiotics.
(5)计数菌落,计算转化率,转化率为每μg质粒DNA产生的转化子数。(5) Count the colonies and calculate the transformation rate. The transformation rate is the number of transformants produced per μg of plasmid DNA.
单独加入不同浓度的甘氨酸,苏氨酸,DTT对枯草芽孢杆菌转化率影响, 结果如图3所示。由图3可知,甘氨酸的终浓度范围在0.6~0.8%,苏氨酸的终浓度范围在0.7~0.9%时,DTT的终浓度范围在5~7mM时,转化效率较好。Separate addition of different concentrations of glycine, threonine, and DTT affect the transformation rate of Bacillus subtilis, and the results are shown in Figure 3. It can be seen from Figure 3 that when the final concentration of glycine is in the range of 0.6-0.8%, the final concentration of threonine is in the range of 0.7-0.9%, and the final concentration of DTT is in the range of 5-7mM, the conversion efficiency is better.
实施例4Example 4
在筛选出转化效率较好的甘氨酸,苏氨酸,DTT的终浓度范围的基础上,将其进行组合,进一步筛选出3中组分的最佳配比,具体配比如下表1,其余操作条件与实施例1相同。After screening the final concentration range of glycine, threonine and DTT with better conversion efficiency, combine them to further screen out the best ratio of the three components. The specific ratio is shown in Table 1 below, and the remaining operations The conditions are the same as in Example 1.
表1.不同浓度的甘氨酸、苏氨酸、DDT组合分组Table 1. Different concentrations of glycine, threonine, and DDT combination grouping
Figure PCTCN2019111571-appb-000003
Figure PCTCN2019111571-appb-000003
结果如图4所示,组别3、6、10~18均有较高的转化率。并且,转化效率并非随着组分浓度的增加而提高,转化效率与甘氨酸,苏氨酸,DTT的浓度不是简单的呈正相关性,三者之间通过复配具有一定的协同作用。因此,通过上述实验筛选,组别12的转化效果最好,即甘氨酸,苏氨酸,DTT的终浓度分别为0.6%(W/V)、0.9%(W/V)、6mmol时枯草芽孢杆菌的转化效果好,是本发 明的最佳方案。The results are shown in Figure 4. Groups 3, 6, 10-18 all have higher conversion rates. Moreover, the conversion efficiency does not increase with the increase of the component concentration. The conversion efficiency is not simply positively correlated with the concentration of glycine, threonine, and DTT, and the three have a certain synergistic effect through compounding. Therefore, through the above experimental screening, the transformation effect of group 12 is the best, that is, the final concentrations of glycine, threonine, and DTT are 0.6% (W/V), 0.9% (W/V), and Bacillus subtilis when the final concentration is 6 mmol. The conversion effect is good, which is the best solution of the present invention.
以上所述实施例仅表达了本发明的几种实施方式,其描述较为具体和详细,但并不能因此而理解为对发明专利范围的限制。应当指出的是,对于本领域的普通技术人员来说,在不脱离本发明构思的前提下,还可以做出若干变形和改进,这些都属于本发明的保护范围。因此,本发明专利的保护范围应以所附权利要求为准。The above-mentioned embodiments only express several embodiments of the present invention, and the descriptions are relatively specific and detailed, but they should not be understood as limiting the scope of the invention patent. It should be pointed out that for those of ordinary skill in the art, without departing from the concept of the present invention, several modifications and improvements can be made, and these all fall within the protection scope of the present invention. Therefore, the protection scope of the patent of the present invention should be subject to the appended claims.

Claims (10)

  1. 一种用于制备枯草芽孢杆菌感受态细胞的细胞壁弱化剂,其特征在于,所述细胞壁弱化剂包括以下组分:甘氨酸、丝氨酸和二硫苏糖醇。A cell wall weakening agent for preparing Bacillus subtilis competent cells is characterized in that the cell wall weakening agent comprises the following components: glycine, serine and dithiothreitol.
  2. 如权利要求1所述的用于制备枯草芽孢杆菌感受态细胞的细胞壁弱化剂,其特征在于,所述甘氨酸、丝氨酸和二硫苏糖醇在所述细胞壁弱化剂中的终浓度为:甘氨酸为0.5~1%(W/V),丝氨酸为0.5~1%(W/V),二硫苏糖醇为1~10mmol。The cell wall weakening agent for preparing Bacillus subtilis competent cells according to claim 1, wherein the final concentration of the glycine, serine and dithiothreitol in the cell wall weakening agent is: glycine is 0.5-1% (W/V), serine 0.5-1% (W/V), dithiothreitol 1-10 mmol.
  3. 如权利要求2所述的用于制备枯草芽孢杆菌感受态细胞的细胞壁弱化剂,其特征在于,所述甘氨酸、丝氨酸和二硫苏糖醇在所述细胞壁弱化剂中的浓度为:甘氨酸为0.6~0.8%(W/V),丝氨酸为0.7~0.9%(W/V),二硫苏糖醇为5~7mmol。The cell wall weakening agent for preparing Bacillus subtilis competent cells according to claim 2, wherein the concentration of the glycine, serine and dithiothreitol in the cell wall weakening agent is: glycine is 0.6 ~0.8%(W/V), serine is 0.7~0.9%(W/V), dithiothreitol is 5~7mmol.
  4. 如权利要求3所述的用于制备枯草芽孢杆菌感受态细胞的细胞壁弱化剂,其特征在于,所述甘氨酸、丝氨酸和二硫苏糖醇在所述细胞壁弱化剂中的浓度为:甘氨酸为0.6%(W/V),丝氨酸为0.9%(W/V),二硫苏糖醇为6mmol。The cell wall weakening agent for preparing Bacillus subtilis competent cells according to claim 3, wherein the concentration of the glycine, serine and dithiothreitol in the cell wall weakening agent is: glycine is 0.6 %(W/V), serine is 0.9%(W/V), dithiothreitol is 6mmol.
  5. 一种枯草芽孢杆菌感受态细胞的电击转化方法,其特征在于,包括制备感受态细胞和电击转化两个步骤,其中,所述制备感受态细胞依次包括以下步骤:A method for electric shock transformation of Bacillus subtilis competent cells is characterized in that it comprises two steps of preparing competent cells and electric shock transformation, wherein the preparing competent cells sequentially includes the following steps:
    (1)将枯草芽孢杆菌接种至LB培养基中过夜培养,再将其接种于GM培养基中培养;(1) Inoculate Bacillus subtilis into LB medium for overnight cultivation, and then inoculate it into GM medium for cultivation;
    (2)在步骤(1)中培养物中加入权利要求1所述的细胞壁弱化剂继续培养至OD600的值达到0.9;(2) In step (1), the cell wall weakening agent according to claim 1 is added to the culture to continue the culture until the value of OD600 reaches 0.9;
    (3)将步骤(2)获得的培养物冰浴,离心收集枯草芽孢杆菌细胞;(3) Centrifuge the culture obtained in step (2) in an ice bath to collect Bacillus subtilis cells;
    (4)使用预冷的WB缓冲液清洗细胞,再将获得的细胞用WB缓冲液重悬,放入液氮中速冻保存;(4) Wash the cells with pre-cooled WB buffer, then resuspend the obtained cells in WB buffer, and put them in liquid nitrogen for quick freezing and storage;
    GM培养基的组分为:胰蛋白胨1%(W/V),酵母提取物0.5%(W/V), NaCl 0.5%(W/V),水解酪蛋白0.2%(W/V),500mM的山梨醇,500mM的葡糖糖,50mM K 2HPO 4,50mM KH 2PO 4The components of GM medium are: tryptone 1% (W/V), yeast extract 0.5% (W/V), NaCl 0.5% (W/V), hydrolyzed casein 0.2% (W/V), 500mM Sorbitol, 500mM glucose, 50mM K 2 HPO 4 , 50mM KH 2 PO 4 .
    WB缓冲液的组分为:500mM的海藻糖,500mM的山梨醇,500mM的甘露醇,0.5mM K 2HPO 4,0.5mM KH 2PO 4,15mM MgCl 2,85mM CaCl 2,pH值7.2。 The components of the WB buffer are: 500 mM trehalose, 500 mM sorbitol, 500 mM mannitol, 0.5 mM K 2 HPO 4 , 0.5 mM KH 2 PO 4 , 15 mM MgCl 2 , 85 mM CaCl 2 , pH 7.2.
    所述电击转化包括如下步骤:The electric shock conversion includes the following steps:
    将待转化的质粒与所述感受态细胞混匀并冰浴,并进行电击,电击转化后于30℃热激5min;得到导入所述待转化治疗的重组枯草芽孢杆菌。The plasmid to be transformed and the competent cell are mixed and bathed in ice, and subjected to electric shock. After electric shock transformation, heat shock at 30° C. for 5 min; to obtain the recombinant Bacillus subtilis which is introduced into the transformation treatment.
  6. 如权利要求5所述的枯草芽孢杆菌感受态细胞的电击转化方法,其特征在于,所述步骤(1)中接种于GM培养基的接种量为1:100,在GM培养基培养至OD600=0.6。The method for electroporation transformation of Bacillus subtilis competent cells according to claim 5, wherein the inoculation amount of the GM medium in the step (1) is 1:100, and the GM medium is cultured to OD600= 0.6.
  7. 如权利要求5所述的枯草芽孢杆菌感受态细胞的电击转化方法,其特征在于,所述电击参数为:电压20kv/cm,电容25μF,电阻200Ω,电击1次,持续时间5ms。The method for electric shock transformation of Bacillus subtilis competent cells according to claim 5, wherein the electric shock parameters are: voltage 20 kv/cm, capacitance 25 μF, resistance 200 Ω, electric shock 1 time, duration 5 ms.
  8. 如权利要求5所述的枯草芽孢杆菌感受态细胞的电击转化方法,其特征在于,所述步骤电击转化还包括将电击转化后的重组枯草芽孢杆菌加入RM培养基于37℃培养3-6小时后涂LB平板;The method for electric shock transformation of Bacillus subtilis competent cells according to claim 5, wherein the step of electric shock transformation further comprises adding the recombinant Bacillus subtilis transformed by electric shock to RM medium and culturing at 37°C for 3-6 hours. Coated LB plate;
    所述RM培养基的组分为胰蛋白胨1%(W/V),酵母提取物0.5%(W/V),NaCl 0.5%(W/V),山梨糖醇500mM,350mM的甘露醇。The components of the RM medium are tryptone 1% (W/V), yeast extract 0.5% (W/V), NaCl 0.5% (W/V), sorbitol 500 mM, 350 mM mannitol.
  9. 如权利要求5所述的枯草芽孢杆菌感受态细胞的电击转化方法,其特征在于,所述枯草芽孢杆菌为枯草芽孢杆菌ZK、枯草芽孢杆菌DB104或枯草芽孢杆菌WB600的其中一种。The method for electroporation transformation of Bacillus subtilis competent cells according to claim 5, wherein the Bacillus subtilis is one of Bacillus subtilis ZK, Bacillus subtilis DB104 or Bacillus subtilis WB600.
  10. 如权利要求5所述的枯草芽孢杆菌感受态细胞的电击转化方法,其特征在于,所述质粒为穿梭质粒PHT01或PHT304。The method for electroporation transformation of Bacillus subtilis competent cells according to claim 5, wherein the plasmid is a shuttle plasmid PHT01 or PHT304.
PCT/CN2019/111571 2019-09-30 2019-10-17 Preparation and transformation methods for bacillus subtilis competent cell WO2021062886A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CN201910943271.3 2019-09-30
CN201910943271.3A CN110484480B (en) 2019-09-30 2019-09-30 Preparation and transformation method of bacillus subtilis competent cells

Publications (1)

Publication Number Publication Date
WO2021062886A1 true WO2021062886A1 (en) 2021-04-08

Family

ID=68544825

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/CN2019/111571 WO2021062886A1 (en) 2019-09-30 2019-10-17 Preparation and transformation methods for bacillus subtilis competent cell

Country Status (2)

Country Link
CN (1) CN110484480B (en)
WO (1) WO2021062886A1 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN114958684A (en) * 2022-06-22 2022-08-30 上海龙殷生物科技有限公司 Method for improving competent cell transformation rate

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN113151022B (en) * 2021-05-28 2023-05-02 武汉华美生物工程有限公司 Preparation method and transformation method for efficiently transforming competent cells of pichia pastoris

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102212546A (en) * 2011-02-28 2011-10-12 福建福大百特科技发展有限公司 Integrative Candida maltose gene expression system and applications thereof
CN102649967A (en) * 2012-05-31 2012-08-29 中国农业大学 Method for transforming wild-type bacillus subtilis
WO2017044476A1 (en) * 2015-09-08 2017-03-16 Massachusetts Institute Of Technology Methods and compositions for recombinase-based genetic diversification
CN109266676A (en) * 2018-09-18 2019-01-25 华南农业大学 A kind of method of electroporated Siam bacillus

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101205546A (en) * 2006-12-22 2008-06-25 上海交通大学医学院附属第九人民医院 Electroporation method for streptococcus mutans
CN105420157A (en) * 2015-12-20 2016-03-23 深圳宏康生物科技有限公司 Preparation of escherichia coli competent cells and transformation method of escherichia coli competent cells
CN107760613A (en) * 2016-08-19 2018-03-06 苏州泓迅生物科技股份有限公司 The re-suspension liquid and saccharomyces cerevisiae electricity of a kind of preparation for turning competent cell for saccharomyces cerevisiae electricity turn the preparation method of competent cell

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102212546A (en) * 2011-02-28 2011-10-12 福建福大百特科技发展有限公司 Integrative Candida maltose gene expression system and applications thereof
CN102649967A (en) * 2012-05-31 2012-08-29 中国农业大学 Method for transforming wild-type bacillus subtilis
WO2017044476A1 (en) * 2015-09-08 2017-03-16 Massachusetts Institute Of Technology Methods and compositions for recombinase-based genetic diversification
CN109266676A (en) * 2018-09-18 2019-01-25 华南农业大学 A kind of method of electroporated Siam bacillus

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
KELLEY DANIELLE S., LENNON CHRISTOPHER W., BELFORT MARLENE, NOVIKOVA OLGA: "Mycobacteriophages as Incubators for Intein Dissemination and Evolution", MBIO, vol. 7, no. 5, 2 November 2016 (2016-11-02), XP055796776, DOI: 10.1128/mBio.01537-16 *
LI RUIFANG, XUE WENWEN, HUANG LIANG, XIONG QIANCHENG, WANG BIN: "Competent Preparation and Plasmid Transformation of Bacillus subtilis", BIOTECHNOLOGY BULLETIN, no. 5, 1 January 2011 (2011-01-01), pages 227 - 230, XP055796788, DOI: 10.13560/j.cnki.biotech.bull.1985.2011.05.035 *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN114958684A (en) * 2022-06-22 2022-08-30 上海龙殷生物科技有限公司 Method for improving competent cell transformation rate

Also Published As

Publication number Publication date
CN110484480A (en) 2019-11-22
CN110484480B (en) 2021-07-06

Similar Documents

Publication Publication Date Title
CN112522173B (en) Engineering bacterium for producing heterologous alkaline protease and construction method thereof
KR102246356B1 (en) Method and application to improve production of Bacillus licheniformis fermentation enzyme through spoⅡQ and pcf gene knockout
WO2021062886A1 (en) Preparation and transformation methods for bacillus subtilis competent cell
WO2019128454A1 (en) Novel trichoderma and application thereof
WO2017186026A1 (en) Method for constructing engineered corynebacterium glutamicum bacteria having high production of l-lysine
WO2021063355A1 (en) Method for constructing food-grade ethanol-degrading bacillus subtilis recombinant bacteria
WO2012126265A1 (en) Recombinant endospore with human serum albumin presented on surface for oral administration and preparation method therefor
CN109234299B (en) Method for expressing and preparing lactobiose phosphorylase
CN108192903B (en) Alkaline xylanase, coding gene and application thereof
CN104131021A (en) Antibacterial peptide coexpression vector, construction and expression method thereof
WO2020134427A1 (en) Use of sll0528 gene in improving ethanol tolerance of synechocystis sp. pcc 6803
CN113699092B (en) Recombinant bacillus subtilis and construction method and application thereof
IL167067A (en) Plasmid-free clone of e. coli strain dsm 6601
CN112522125B (en) Hyaluronidase engineering bacterium and construction method and application thereof
CN111690581B (en) Method for producing ice nucleoprotein by fermentation of recombinant escherichia coli
CN107475140B (en) Recombinant pichia pastoris mutant with high pullulanase yield and improved fermentation speed under acidic condition
CN109628361B (en) Integrated double-copy functional F4 pilus operon gene pig-derived probiotic EP1 clone strain, construction method and application
CN108277176B (en) Alkaliphilic streptomyces, alkaline xylanase produced by same and application of alkaline xylanase
CN107083375B (en) Medium-temperature alpha-amylase and gene and application thereof
Wanker et al. Expression of Bacillus subtilis levanase gene in Lactobacilus plantarum and Lactobacillus casei
WO2018099063A1 (en) Method for efficiently secreting and expressing foreign protein using bacillus
CN115160419B (en) Pichia glabra Thioredoxin secretory protein and application thereof
CN110846265B (en) Burkholderia recombination strain and construction method and application thereof
CN113005114B (en) Enzyme SCXC, coding gene thereof and application of enzyme SCXC in preparation of pine wood nematode killing products
CN115160418B (en) Pichia glabra Peptidase secretion protein and application thereof

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 19947967

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 19947967

Country of ref document: EP

Kind code of ref document: A1